Cargando…
The E3 Ligase TRIM4 Facilitates SET Ubiquitin‐Mediated Degradation to Enhance ER‐α Action in Breast Cancer
Estrogen receptor alpha (ER‐α) action is critical for hormone‐dependent breast cancer, and ER‐α dysregulation can lead to the emergence of resistance to endocrine therapy. Here, it is found that TRIM4 is downregulated in tamoxifen (TAM)‐resistant breast cancer cells, while the loss of TRIM4 is assoc...
Autores principales: | Han, Dianwen, Wang, Lijuan, Long, Li, Su, Peng, Luo, Dan, Zhang, Hanwen, Li, Zheng, Chen, Bing, Zhao, Wenjing, Zhang, Ning, Wang, Xiaolong, Liang, Yiran, Li, Yaming, Hu, Guohong, Yang, Qifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443474/ https://www.ncbi.nlm.nih.gov/pubmed/35843886 http://dx.doi.org/10.1002/advs.202201701 |
Ejemplares similares
-
Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
por: Liu, Ying, et al.
Publicado: (2020) -
The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer
por: Wang, Shan, et al.
Publicado: (2016) -
circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells
por: Li, Zheng, et al.
Publicado: (2023) -
Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53
por: Chen, Yajie, et al.
Publicado: (2019) -
Origin and Diversification of TRIM Ubiquitin Ligases
por: Marín, Ignacio
Publicado: (2012)